NIVFW
Income statement / Annual
Last year (2023), NewGenIvf Group Limited's total revenue was $5.14 M,
a decrease of 13.59% from the previous year.
In 2023, NewGenIvf Group Limited's net income was $130,193.00.
See NewGenIvf Group Limited,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
| Operating Revenue |
$5.14 M |
$5.94 M |
$4.12 M |
| Cost of Revenue |
$3.45 M
|
$4.41 M
|
$3.09 M
|
| Gross Profit |
$1.68 M
|
$1.54 M
|
$1.02 M
|
| Gross Profit Ratio |
0.33
|
0.26
|
0.25
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$1.62 M
|
$1.10 M
|
$801,329.00
|
| Selling & Marketing Expenses |
$18,030.00
|
$36,194.00
|
$24,693.00
|
| Selling, General & Administrative Expenses |
$1.64 M
|
$1.14 M
|
$826,022.00
|
| Other Expenses |
$0.00
|
$23,019.00
|
$45,652.00
|
| Operating Expenses |
$1.64 M
|
$1.14 M
|
$826,022.00
|
| Cost And Expenses |
$5.09 M
|
$5.55 M
|
$3.92 M
|
| Interest Income |
$518.00
|
$21.00
|
$63.00
|
| Interest Expense |
$46,179.00
|
$77,757.00
|
$88,289.00
|
| Depreciation & Amortization |
$229,708.00
|
$303,944.00
|
$342,539.00
|
| EBITDA |
$384,305.00 |
$725,689.00 |
$587,012.00 |
| EBITDA Ratio |
0.07
|
0.12
|
0.14
|
| Operating Income Ratio |
0.01
|
0.07
|
0.05
|
| Total Other Income/Expenses Net |
$66,176.00
|
-$54,717.00
|
-$42,574.00
|
| Income Before Tax |
$108,418.00
|
$343,988.00
|
$156,184.00
|
| Income Before Tax Ratio |
0.02
|
0.06
|
0.04
|
| Income Tax Expense |
$0.00
|
$208,141.00
|
$294,716.00
|
| Net Income |
$130,193.00
|
$458,667.00
|
-$533.00
|
| Net Income Ratio |
0.03
|
0.08
|
-0
|
| EPS |
0 |
0 |
0 |
| EPS Diluted |
0 |
0 |
0 |
| Weighted Average Shares Out |
$0.00
|
$0.00
|
$0.00
|
| Weighted Average Shares Out Diluted |
$0.00
|
$0.00
|
$0.00
|
| Link |
|
|
|
